research

Anacardic acid, a compound found in cashew nuts, promoted myelin regeneration and eased neuronal damage and disability in two mouse models of multiple sclerosis (MS). These protective effects were associated with maturation of myelin-producing cells and production of IL-33, an immune-related molecule with a neuroreparative role in the central…

In people with multiple sclerosis (MS), skin cells show increased amounts of cellular stress in a manner that is distinct from people without MS and from other neurological diseases, new research shows. The findings were published in the journal Aging, in the study “Signatures of cell…

In a $3.68 billion transaction, Sanofi is preparing to acquire Principia Biopharma, a biopharmaceutical company focused on the development of therapies for disorders caused by dysregulation of the immune system, including multiple sclerosis (MS). The decision was unanimously approved by the board of directors of…

A protein known as Gsta4 is critical in the growth and activity of oligodendrocytes, a special type of brain cell that generates the myelin sheath that is damaged in multiple sclerosis (MS), a study shows. The overproduction of Gsta4 in…

Lowering levels of a protein called reelin — which regulates how permeable blood vessels are to immune cells — reduced infiltration of these cells into the central nervous system (CNS), preventing neuroinflammation and disease progression in a mouse model of multiple sclerosis (MS). These data, which also showed that Reelin…

Almost two-thirds of people newly diagnosed with multiple sclerosis (MS) in the United States, identified through a national database, were not prescribed disease-modifying therapies (DMTs) over an average of more than two years of follow-up, a real-world study of nearly 5,700 patients found. Current guidelines “recommend early treatment with…

Multiple sclerosis (MS) patients have high levels of cortisol, a stress hormone, compared to healthy controls. Also, patients categorized as non-cognitive fatigue show a higher variability in cortisol levels and perform worse on an attention task. Those findings are documented in the study, “Relation between cognitive fatigue and circadian…

Inflammation drives the loss of brain volume and thinning of the eye’s retina in the first five years of a multiple sclerosis (MS) diagnosis, an imaging study demonstrates.  The findings support a therapeutic strategy of halting inflammatory activity during this initial period. …

For the first time, scientists have shown that a protein known as CD36 on the surface of some immune cells is crucial for clearing myelin debris and suppressing nerve cell inflammation in disorders such as multiple sclerosis (MS), according to a new…

Therapeutics Solutions International has announced filing a new patent covering the memory protective effects of its natural nutritional supplement QuadraMune, as seen in an animal model of memory loss caused by inflammation. QuadraMune is a nutritional supplement, available in capsule form, made of four ingredients with known anti-inflammatory, neuroprotective, and…

Cigarette smoking and an Epstein–Barr virus infection together represent a significant risk factor for multiple sclerosis (MS), suggesting that at least one path to this disease involves two factors working synergistically, a study reports. The study, “Smoking and Epstein–Barr virus infection in multiple sclerosis development,” was published…

A $41,000 fellowship from the National Institutes of Health (NIH) aims to advance research into how changes in brain connectivity are related to the cognitive deficits seen in people with multiple sclerosis (MS). The Ruth L. Kirschstein National Research Service Award Individual Predoctoral Fellowship was granted to…

Immigrants with multiple sclerosis (MS) in Ontario use public health services as much as long-term residents, but are more likely to be hospitalized during the year in which they are diagnosed, according to a recent study. While reasons for that year’s higher hospitalization rates are not clear, evidence supports…

People with multiple sclerosis (MS) who exercise regularly are able to maintain volume in the hippocampus, a brain region responsible for learning and memory, a study reports. This work “adds to the growing body of evidence that exercise has many benefits for people with MS,” the National MS…

The debilitating mental fatigue that people with multiple sclerosis (MS) can feel after a cognitively demanding task may be due to less efficient use of the brain, a pilot study that mapped brain activity during tasks suggests. The study “Neural mechanisms underlying state mental fatigue in multiple sclerosis: a…

A “prudent” diet rich in fresh fruit, non-fried fish, whole grains, vegetables, and nuts may lower the likelihood of a relapse in people with a first demyelinating event, a major risk factor for multiple sclerosis (MS), a study in Australia suggests. While the researchers did not find a strong link…

Levels of a protein linked to inflammation and neurodegeneration in multiple sclerosis (MS) — called chitinase 3-like-1 (CHI3L1) — may prove to be a cerebrospinal fluid biomarker of neurologic disability in primary progressive MS (PPMS), a pilot study suggests. Higher CHI3L1 levels at PPMS diagnosis showed a…

The pro-inflammatory signaling protein interleukin (IL)-17A, which is associated with nerve damage in multiple sclerosis (MS), also has an opposing, and crucial, anti-inflammatory role in cells, a study reports.  These findings may explain why therapies that lower IL-17A levels have failed…

People with multiple sclerosis (MS) spend a significantly greater number of work days each year on sick leave or disability pay than do the general population — including in the years before they are formally diagnosed, a Swedish study found. Though the number of missed work days rises in…

A variant of the HLA-DPB1 gene — called HLA-DPB1*04 — appears to protect people from developing multiple sclerosis (MS) either in childhood or as adults, a study from Greece suggests.

An interactive video game was more effective than a word game at improving processing speeds in multiple sclerosis (MS) patients with cognitive difficulties, and gains measured were longer lasting, a small clinical trial reports. These results were in the study “A novel in-home digital treatment to…

Assessing the cognitive health of people with multiple sclerosis (MS) can be performed using online telehealth, with results similar to in-person testing, researchers working with a patient group reported. “By assessing memory in patients prior to a clinic visit using a web-based approach, we may be able to meet the…

Researchers developed a way of using machine learning to identify those cells most important for a given function or task, such as movement, and for evaluating how they respond to potentially restorative treatments. Using Augur, as this method is called, the team was able to identify the neural circuits in…

The thickness of two layers of nerve cells forming the back of the eye, or retina, can be used to distinguish patients with progressing forms of multiple sclerosis (MS) from those with stable disease, a study suggests. The study, “Macular ganglion cell–inner plexiform layer…

To speed research and work on more personalized treatments for serious diseases, Roche and its subsidiary Genentech announced a partnership with PicnicHealth to access its collection of real-world data. Eligible adults with MS in the United States are also being invited to join a multiyear study assembling such…

A multimedia smartphone application designed to precisely inform about exercise and track physical activity led primary or secondary progressive multiple sclerosis (MS) patients to be more active — but no more than a comparison patient group given only a…

The National Multiple Sclerosis Society announced investments of more than $16 million to support 50 new multi-year research projects and training fellowships addressing multiple sclerosis (MS). This latest series of investments, made over the spring, raised to $65 million total global research funding by the society. Although the…

NeuroScientific Biopharmaceuticals (NSB)’s lead candidate EmtinB induces significantly greater myelin regeneration in a cellular model of multiple sclerosis (MS) than the market-leading therapy Copaxone, the company announced. “These results represent a potential breakthrough in the treatment of MS as there are currently no approved therapeutic drugs available to patients that…

High levels of neurofilament light chain (NfL) protein circulating in the blood of patients with multiple sclerosis (MS) at an early stage of the disease are linked to higher disability and faster disease progression, a study has found. According to researchers, these findings suggest that NfL — a…

The ongoing COVID-19 pandemic is disrupting vital care and support for those with neurological disorders like multiple sclerosis (MS), according to a recent report from the Neurological Alliance in the U.K. The report is based upon survey responses from over 1,600 people with neurological conditions in that…